MO.MA -- a new cerebral stroke protection system during carotid artery stenting

Dariusz Dudek1, Stanisław Bartuś, Tomasz Rakowski

  • 1II Klinika Kardiologii Instytutu Kardiologii; Collegium Medicum, Uniwersytet Jagielloński, Kraków.

Kardiologia Polska
|August 27, 2005
PubMed

Insights

The MO.MA system effectively prevents stroke during carotid angioplasty and stenting (CAS). This novel cerebral protection device demonstrated safety and efficacy in a study of 21 patients undergoing CAS procedures.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Neurology

Background:

  • Carotid angioplasty and stenting (CAS) is an alternative to carotid endarterectomy for carotid atherosclerosis.
  • Cerebral protection devices are mandatory during CAS due to embolization risks.

Purpose of the Study:

  • To evaluate the safety and efficacy of the MO.MA cerebral protection device.
  • Assessing the MO.MA system's performance in patients undergoing CAS.

Main Methods:

  • The study included 21 patients undergoing carotid stenting.
  • Evaluated MO.MA system's deliverability, procedural success, and adverse event rates.

Main Results:

  • All CAS procedures using the MO.MA system were successful.
  • No major cerebrovascular complications occurred during 30-day and 6-month follow-ups.

Conclusions:

  • The MO.MA system is a safe and effective tool for stroke prevention during CAS.
  • The MO.MA system provides reliable cerebral protection in CAS procedures.
Abstract